Brickell Biotech Inc. Stock News

Vical (NASDAQ:VICL) and Jounce Therapeutics (NASDAQ:JNCE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their pro

Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s

Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s

Best Practices to Leverage from BBI's Human Social Responsibility Report to help build a fantastic CSR program, or enhance your current one.

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares surged 84% to $3.3525 following news Phase 2b study results for its sofpironium bromide hyperhidrosis treatment were published...

Keeping a finger on the pulse of developments in the market requires constant attention. Turn your head, and in the blink of an eye prospective investments have already shot up on the back of good new

Brickell Biotech (NASDAQ:BBI) +64% on positive sofpironium bromide data.Adesto Technologies (NASDAQ:IOTS) +55% on being acquired by Dialog Semiconductor.Stamps.com (NASDAQ:STMP) +39% on Q4 results.

Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s

Gainers Stealth BioTherapeutics, Inc. (NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H...

Brickell Biotech, Inc. and its subsidiary (collectively, “Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics fo

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS

Adaptimmune Therapeutics PLC (NASDAQ:ADAP) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors.Verona Pharma PLC (NASDAQ:VRNA) +54% on positive ensifentrine data.Mereo BioP

Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s